Navigation Links
InteKrin Therapeutics Presents Positive Long Term INT131 Preclinical Cardiovascular Safety Data at the 45th Annual European Association for the Study of Diabetes Meeting
Date:9/30/2009

carcinogenicity following lifetime exposure to INT131. These results are enabling for INT131 to initiate planned Phase 3 clinical studies.

INT131 is a next-generation insulin sensitizer that addresses insulin resistance, a key etiological feature in the onset and subsequent progression of type 2 diabetes. INT131 has been designed to provide a safer therapeutic tool for physicians and patients, which is complementary to available classes of medications, and allows for powerful glucose control and the opportunity for modification of the underlying disease. As a SPPARM, INT131 selectively modulates PPAR-gamma, and is ideally positioned to safely improve insulin resistance, addressing an important unmet medical need.

About InteKrin (www.InteKrin.com):

InteKrin Therapeutics is a privately-held clinical-stage drug development company focused on diabetes, obesity and metabolic disease. InteKrin's business strategy is to build a robust portfolio of high value products by in-licensing clinical-stage therapeutic candidates that address significant unmet medical needs and rapidly move them through critical development stages. InteKrin's team of world-class scientific and medical experts includes veterans from several successful BioPharma organizations, internationally recognized experts in nuclear receptors and metabolism, top scientists formerly with the Food and Drug Administration and key clinical and commercialization leaders.

SOURCE InteKrin Therapeutics Inc.


'/>"/>
SOURCE InteKrin Therapeutics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. InteKrin Therapeutics Announces Initiation of Phase 2b Study in Type 2 Diabetes with INT131
2. InteKrin Therapeutics Announces Enrollment Completion of 360 Patient, 24 week Phase 2b Study
3. InteKrin Therapeutics to Present at the 2009 American Diabetes Association Annual Meeting
4. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
5. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
6. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
7. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
8. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
9. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
10. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
11. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... July 29, 2014 New technology in the ... allow physicians to see and assess brain tissue more ... to study authors who released their findings today at ... Annual Meeting in Colorado Springs, CO. ... field of neurointervention, a specialty that facilitates stroke treatment ...
(Date:7/29/2014)... HILL, Conn. , July 29, 2014 Numotion,s ... 2014, Mike Swinford will be the company,s new ... a highly successful 22-year career at GE where he worked ... million in annual revenue to over $5 billion. His most ... Global Services. "I am thrilled to join ...
(Date:7/29/2014)... Fla. , July 29, 2014 /PRNewswire-iReach/ -- ... service provider, has launched its Medical Equipment ...  These services are tailored to the cruise ... standards prompted industry operators to propose that they ... MHG Medical,s new program is intended to create ...
Breaking Medicine Technology:New Technology May Improve Visualization Of The Brain During Stroke Treatment 2New Technology May Improve Visualization Of The Brain During Stroke Treatment 3Numotion Names Mike Swinford CEO 2MHG Medical Management Services Aims to Change Cruise Industry Standard With New Equipment Maintenance Program 2
... NHS National Innovation Centre supports the cost ... Medical announced today the findings of an independent economic ... Innovation Centre, the NHS organization which supports innovators, commissioners, ... of innovations that will benefit the NHS. ...
... --  Janet R. Dees, CEO/President of American Vascular Access, ... newest vascular access center in Columbus, Georgia.  "Our Newnan, ... Vascular Access, LLC., and the addition of the Columbus, ... "Our goal has continued to be to ...
Cached Medicine Technology:NHS National Innovation Centre Estimates Sequana Medical's ALFApump® System Could Save the NHS £50 Million in ascites Care Annually 2American Vascular Access Continues Growth in Georgia 2
(Date:7/30/2014)... NY (PRWEB) July 30, 2014 Running ... Dr Steven Shoshany aims to help runners keep ... techniques to help athletes continue training. He has recently ... ART (Active Release Techniques), Cold Laser Therapy, Graston technique ... injury free. , Dr Shoshany often combines ...
(Date:7/30/2014)... AttorneyOne.com, a recognized authority on law, ... from the FDA on snacks . , Dancing ... are recalled because they contain organic Carob ... salmonella. Salmonella can cause serious, fatal infections in people ... cause abdominal pain, vomiting, nausea, diarrhea, or fever. In ...
(Date:7/30/2014)... The Diabetes Daily Grind had its ... and Ryan Fightmaster hope to gain attention for the ... July 26th of this year, Clour and Fightmaster started ... the diabetic life. By sharing stories on their ... believe other diabetics will find ways to live with ...
(Date:7/30/2014)... July 30, 2014 An interesting fact ... community where motorcycle enthusiasts congregate, BikerKiss.com . The ... that were revealed by BikerKiss indicate that women motorcycle ... past 3 years. , Members on BikerKiss are mostly ... Australia and some other European countries who are there ...
(Date:7/30/2014)... 30, 2014 According to the Nasal Polyps ... a comprehensive guide that teaches people how to cure their ... book uncovers to readers the horrible truth about conventional treatments ... that inside this book, people will learn how to prevent ... asthma, and nasal infections. , Nasal Polyps Treatment Miracle, as ...
Breaking Medicine News(10 mins):Health News:Chiropractor Helping Runners Keep Going with New Integrated Treatment Protocols 2Health News:Chiropractor Helping Runners Keep Going with New Integrated Treatment Protocols 3Health News:Various Snacks by Dancing Star Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Various Snacks by Dancing Star Recalled: AttorneyOne Monitors and Keeps Consumers Informed 3Health News:Strangers Come Together to Form Diabetes Website: Real Messages of Hope and Inspiration 2Health News:Single Women Motorcycle Riders In Rapid Increase 2Health News:Nasal Polyps Treatment Miracle Book Review Exposes Manuel Richards' Guide For Treating Nasal Polyps – Vkool.com 2Health News:Nasal Polyps Treatment Miracle Book Review Exposes Manuel Richards' Guide For Treating Nasal Polyps – Vkool.com 3
... ... ... ... HOUSTON , March 1 Despite Northstar management,s recent claim ...
... ... on Executive Position , ... Tucson, Ariz. (Vocus) February 28, 2010 -- Tom Rios has been promoted to ... Most recently, he had been Splendido’s director of accounting., , ,Rios will work with ...
... ... ... ... ...
... ... ... ... , , ...
... ... ... ... ...
... Researchers from The University of Texas M. D. Anderson ... measure the severity of symptoms that can complicate stem ... graft-versus-host disease (cGVHD), and was presented with supporting research ... cGVHD - a chronic disease that requires ...
Cached Medicine News:Health News:Northstar Management Forecasts a Loss of $1.2 Million for 2010 at Its Palladium for Surgery -- Houston, Ltd. Centre 2Health News:Tom Rios Named Executive Director at Splendido 2Health News:AMA: Physicians Outraged at Today's Steep Medicare Cut 2Health News:AMA: Physicians Outraged at Today's Steep Medicare Cut 3Health News:AMA: Physicians Outraged at Today's Steep Medicare Cut 4Health News:AMA: Physicians Outraged at Today's Steep Medicare Cut 5Health News:AMA: Physicians Outraged at Today's Steep Medicare Cut 6Health News:AMA: Physicians Outraged at Today's Steep Medicare Cut 7Health News:HCA Announces Offering of $1.0 Billion Senior Secured First Lien Notes 2Health News:HCA Announces Offering of $1.0 Billion Senior Secured First Lien Notes 3Health News:HCA Announces Offering of $1.0 Billion Senior Secured First Lien Notes 4Health News:Aflac Incorporated to Present at the Raymond James 31st Annual Institutional Investors Conference 2Health News:Aflac Incorporated to Present at the Raymond James 31st Annual Institutional Investors Conference 3Health News:Aflac Incorporated to Present at the Raymond James 31st Annual Institutional Investors Conference 4Health News:Aflac Incorporated to Present at the Raymond James 31st Annual Institutional Investors Conference 5Health News:M. D. Anderson develops tool to measure severity of chronic graft-vs.-host disease symptoms 2Health News:M. D. Anderson develops tool to measure severity of chronic graft-vs.-host disease symptoms 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: